echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Hengrui wins the first review with 2 billion anesthetics

    Hengrui wins the first review with 2 billion anesthetics

    • Last Update: 2021-10-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Author: Bai Yu

    A few days ago, Hengrui Pharmaceuticals issued an announcement stating that the company has been approved for inhalation sevoflurane for imitation of the 4 types of applications and is deemed to have been reviewed.


    Drug-related situation

    Data show that sevoflurane for inhalation enters the human body through the respiratory tract in the form of volatile gas to form anesthesia, which is suitable for the induction and maintenance of general anesthesia for adults and children


    Sales of sevoflurane for terminal inhalation in public medical institutions in China in recent years (unit: 100 million yuan)

    Source: Mi Nei.


    Sevoflurane for inhalation was developed by Maruishi Pharmaceutical Co.


    Source: One-click search on Mi Nei.


    Prior to this, there were five domestic manufacturers of sevoflurane for inhalation, including Maruishi Pharmaceutical Co.


    Up to now, Hengrui Medicine has invested about 13.


    Source: Listed company announcements, Mi Nei.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.